Top

Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past

One Texas Judge Will Decide Fate of Abortion Pill Used by Millions of American Women

EU drug regulator has not found any signs of Pfizer COVID shot linking to stroke

New York nurses reach deals on third day of strike

Venture capital healthtech funding drops 41.2% as firms brace for economic decline

Tag: Nectin Therapeutics

Biomarker, Innovation

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies

November 30, 2022

Via: HitConsultant

The company also announced dosing of the first patient in its Phase 1 clinical trial of NTX1088, Nectin’s first-in-class PVR blocker, in cancer patients with locally advanced and metastatic solid tumors. NTX1088 is a first-in-class high affinity monoclonal antibody directed […]

Tag: Nectin Therapeutics

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies

Latest Publications

FDA Spurs Conversation about AI and ML in Drug Development and Manufacturing

Securing mergers and acquisitions in healthcare

WHO chief warns of future pathogens with ‘even deadlier potential’ than COVID-19

Tag: Nectin Therapeutics

Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies

Trending

Tags

Latest Publications

FDA Spurs Conversation about AI and ML in Drug Development and Manufacturing

Securing mergers and acquisitions in healthcare

WHO chief warns of future pathogens with ‘even deadlier potential’ than COVID-19